510(k) K951799
K951799 is an FDA 510(k) premarket notification submitted by Light Diagnostics for the device "VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY". The FDA issued a decision of Substantially Equivalent on March 20, 1996. The device falls under product code GQX (Antiserum, Cf, Varicella-Zoster), a Class II device regulated under 21 CFR 866.3900. Light Diagnostics has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 20, 1996
- Date Received
- April 19, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antiserum, Cf, Varicella-Zoster
- Device Class
- Class II
- Regulation Number
- 866.3900
- Review Panel
- MI
- Submission Type